Advancements in NSCLC Treatment

This chapter explores the evolving treatment landscape for non-small cell lung cancer, emphasizing immunotherapy and targeted therapies. It examines the implications of biomarkers, treatment decisions based on genetic factors, and contrasts chemotherapy with immunotherapy in various patient scenarios.